186 related articles for article (PubMed ID: 19882375)
1. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease.
Kitajima Y; Eguchi Y; Ishibashi E; Nakashita S; Aoki S; Toda S; Mizuta T; Ozaki I; Ono N; Eguchi T; Arai K; Iwakiri R; Fujimoto K
J Gastroenterol; 2010 Feb; 45(2):218-24. PubMed ID: 19882375
[TBL] [Abstract][Full Text] [Related]
2. The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies.
Koda M; Kawakami M; Murawaki Y; Senda M
J Gastroenterol; 2007 Nov; 42(11):897-903. PubMed ID: 18008034
[TBL] [Abstract][Full Text] [Related]
3. Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle.
Kitajima Y; Hyogo H; Sumida Y; Eguchi Y; Ono N; Kuwashiro T; Tanaka K; Takahashi H; Mizuta T; Ozaki I; Eguchi T; Kimura Y; Fujimoto K; Anzai K;
J Gastroenterol Hepatol; 2013 Sep; 28(9):1507-14. PubMed ID: 23577962
[TBL] [Abstract][Full Text] [Related]
4. Visceral adipose tissue area is an independent risk factor for hepatic steatosis.
Park BJ; Kim YJ; Kim DH; Kim W; Jung YJ; Yoon JH; Kim CY; Cho YM; Kim SH; Lee KB; Jang JJ; Lee HS
J Gastroenterol Hepatol; 2008 Jun; 23(6):900-7. PubMed ID: 17995942
[TBL] [Abstract][Full Text] [Related]
5. Validation of intimate correlation between visceral fat and hepatic steatosis: Quantitative measurement techniques using CT for area of fat and MR for hepatic steatosis.
Choi MH; Choi JI; Park MY; Rha SE; Oh SN; Jung SE; Byun JY; Kannengiesser S; Son Y
Clin Nutr; 2018 Feb; 37(1):214-222. PubMed ID: 28049553
[TBL] [Abstract][Full Text] [Related]
6. The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.
Eguchi Y; Mizuta T; Sumida Y; Ishibashi E; Kitajima Y; Isoda H; Horie H; Tashiro T; Iwamoto E; Takahashi H; Kuwashiro T; Soejima S; Kawaguchi Y; Oda Y; Emura S; Iwakiri R; Ozaki I; Eguchi T; Ono N; Anzai K; Fujimoto K; Koizumi S
J Gastroenterol; 2011 Jan; 46 Suppl 1():70-8. PubMed ID: 21042922
[TBL] [Abstract][Full Text] [Related]
7. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Fenkci S; Rota S; Sabir N; Akdag B
Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
[TBL] [Abstract][Full Text] [Related]
10. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.
Ishibashi E; Eguchi Y; Eguchi T; Matsunobu A; Oza N; Nakashita S; Kitajima Y; Kuroki S; Ozaki I; Kawaguchi Y; Ide Y; Yasutake T; Iwakiri R; Mizuta T; Ono N; Fujimoto K
J Gastroenterol Hepatol; 2008 Jun; 23(6):908-13. PubMed ID: 18373563
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
[TBL] [Abstract][Full Text] [Related]
12. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
[TBL] [Abstract][Full Text] [Related]
13. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome.
Taira S; Shimabukuro M; Higa M; Yabiku K; Kozuka C; Ueda R; Sunagawa S; Ohshiro Y; Doi M; Nanba T; Kawamoto E; Nakayama Y; Nakamura H; Iha T; Nakachi S; Tomoyose T; Ikema T; Yamakawa K; Masuzaki H
Intern Med; 2013; 52(14):1561-71. PubMed ID: 23857087
[TBL] [Abstract][Full Text] [Related]
14. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
Eguchi Y; Eguchi T; Mizuta T; Ide Y; Yasutake T; Iwakiri R; Hisatomi A; Ozaki I; Yamamoto K; Kitajima Y; Kawaguchi Y; Kuroki S; Ono N
J Gastroenterol; 2006 May; 41(5):462-9. PubMed ID: 16799888
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome.
Pickhardt PJ; Jee Y; O'Connor SD; del Rio AM
AJR Am J Roentgenol; 2012 May; 198(5):1100-7. PubMed ID: 22528899
[TBL] [Abstract][Full Text] [Related]
16. Computerized Tomography Based Diagnosis of Visceral Obesity and Hepatic Steatosis is Associated with Low Urine pH.
Patel ND; Ward RD; Calle J; Remer EM; Monga M
J Urol; 2017 Nov; 198(5):1085-1090. PubMed ID: 28587918
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.
Sogabe M; Okahisa T; Hibino S; Yamanoi A
J Gastroenterol; 2012 Mar; 47(3):293-9. PubMed ID: 22065161
[TBL] [Abstract][Full Text] [Related]
18. Obesity-Induced Hepatic Steatosis Is Partly Mediated by Visceral Fat Accumulation in Subjects with Overweight/Obesity: A Cross-Sectional Study.
Liu F; Chen S; Li X; Li S; Xiao Y; Han J; Tu Y; Bao Y; Bai W; Yu H
Obes Facts; 2023; 16(2):164-172. PubMed ID: 36257286
[TBL] [Abstract][Full Text] [Related]
19. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
20. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
